The latest closing stock price for Adaptimmune Therapeutics as of November 20, 2024 is 0.66.
An investor who bought $1,000 worth of Adaptimmune Therapeutics stock at the IPO in 2015 would have $-958 today, roughly -1 times their original investment - a -27.25% compound annual growth rate over 10 years.
The all-time high Adaptimmune Therapeutics stock closing price was 21.12 on June 16, 2015.
The Adaptimmune Therapeutics 52-week high stock price is 2.05, which is 210.6% above the current share price.
The Adaptimmune Therapeutics 52-week low stock price is 0.42, which is 36.4% below the current share price.
The average Adaptimmune Therapeutics stock price for the last 52 weeks is 1.03.
An investor who bought $1,000 worth of Adaptimmune Therapeutics stock at the IPO in 2015 would have $-958 today, roughly -1 times their original investment - a -27.25% compound annual growth rate over 10 years.
The all-time high Adaptimmune Therapeutics stock closing price was 21.12 on June 16, 2015.
The Adaptimmune Therapeutics 52-week high stock price is 2.05, which is 210.6% above the current share price.
The Adaptimmune Therapeutics 52-week low stock price is 0.42, which is 36.4% below the current share price.
The average Adaptimmune Therapeutics stock price for the last 52 weeks is 1.03.